The name of the issuer is Colfax Corporation, a Delaware corporation (the “Issuer”).
Item 1(b) | Address of Issuer’s Principal Executive Offices: |
The principal executive office of the Issuer is 2711 Centerville Road, Suite 400, Wilmington, DE 19808.
Item 2(a) | Name of Person Filing: |
This Schedule is being filed by Steven M. Rales (the “Reporting Person”).
Item 2(b) | Address of Principal Business Office, or, if None, Residence: |
The principal business address of the Reporting Person is 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC 20037.
The Reporting Person is a citizen of the United States of America.
Item 2(d) | Title of Class of Securities: |
This Schedule 13G/A relates to the common stock of the Issuer, par value $0.001 per share (the “Common Stock”).
The CUSIP Number of the Common Stock is 194014106.
Item 3 | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
N/A
| (a) | Amount beneficially owned: 8,410,679 |
| (b) | Percent of class: 5.43% |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 8,410,679 |
| (ii) | Shared power to vote or to direct the vote: 0 |
| (iii) | Sole power to dispose or to direct the disposition of: 8,410,679 |
| (iv) | Shared power to dispose or to direct the disposition of: 0 |